KR920002632A - 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질 및 이를 함유하는 백신 - Google Patents

면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질 및 이를 함유하는 백신 Download PDF

Info

Publication number
KR920002632A
KR920002632A KR1019910012309A KR910012309A KR920002632A KR 920002632 A KR920002632 A KR 920002632A KR 1019910012309 A KR1019910012309 A KR 1019910012309A KR 910012309 A KR910012309 A KR 910012309A KR 920002632 A KR920002632 A KR 920002632A
Authority
KR
South Korea
Prior art keywords
protein
class
outer membrane
neisseria meningitidis
antigen
Prior art date
Application number
KR1019910012309A
Other languages
English (en)
Inventor
아이. 올리프 앨런
에이. 류 마거릿
프리드만 아더
와이. 타이 죠셉
제이. 돈넬리 죤
Original Assignee
제임스 에프. 노턴
머크 앤드 캄파니, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제임스 에프. 노턴, 머크 앤드 캄파니, 인코포레이티드 filed Critical 제임스 에프. 노턴
Publication of KR920002632A publication Critical patent/KR920002632A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음

Description

면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 Ⅱ 단백질 및 이를 함유하는 백신
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 PRP-OMPC로 면역화한 후 일정일에 취한 혈액 샘플에서 ELISA 및 RIA로 측정한, PRP-DT 및 MIEP, 또는 OMPC, 또는 IAA-OMPC로 개별적으로 프라이밍된 비장 세포를 수용하는 채택성 이전 수용자의 항체 반응도이다.
제2도는 시험관내에서 수행한 MIEP의 마이토젠(mitogen)활성에 대한 림프구 증식 검정도이다.
제3도는 PRP-MIEP 접합체의 마우스 및 새끼 붉은털 원숭이에서 수행한 면역원성 시험도이다.

Claims (4)

  1. 항원에 결합된 나이세리아 메닌자이티디스(Neisseria meningitidis) 혈청 그룹 B의 외막의 클래스 Ⅱ 단백질을 함유하고, 포유동물에서 상기 항원에 특이적인 항체의 형성을 유발하거나 강화시키는 포유동물용 백신.
  2. 제1항에 있어서, 항원이 세균, 바이러스, 포유동물세포, 진균, 리케챠, 알레르젠(allergen), 독(poisons) 또는 뱀독(venoms), 합성 펩타이드 및 폴리펩타이드 단편중에서 유도되는 방법.
  3. 제1항에 있어서, 나이세리아 메닌자이티디스 혈청 그룹 B의 외막의 클래스 Ⅱ 단백질이 재조합 숙주 세포에서 생성된 재조합 단백질인 백신.
  4. 헤모필루스 인플루엔제(Haemophilus influenzae) 혈청형 B 다당류와 나이세리아 메닌자이티디스 혈청 그룹 B의 클래스 Ⅱ 외막 단백질을 함유하는, 포유류의 면역화에 대한 유효량의 다당류/단백질 결합체 및 약제학적으로 허용되는 담체를 함유하는 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910012309A 1990-07-19 1991-07-19 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질 및 이를 함유하는 백신 KR920002632A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55532990A 1990-07-19 1990-07-19
US07/555,329 1990-07-19
US71527491A 1991-06-19 1991-06-19
US07/715,274 1991-06-19

Publications (1)

Publication Number Publication Date
KR920002632A true KR920002632A (ko) 1992-02-28

Family

ID=27070858

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910012309A KR920002632A (ko) 1990-07-19 1991-07-19 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질 및 이를 함유하는 백신

Country Status (10)

Country Link
JP (1) JPH0655679B2 (ko)
KR (1) KR920002632A (ko)
AU (1) AU8113691A (ko)
CA (1) CA2050635A1 (ko)
FI (1) FI913475A (ko)
IL (1) IL98839A0 (ko)
MX (1) MX9100275A (ko)
NO (1) NO912823L (ko)
NZ (1) NZ238974A (ko)
PT (1) PT98382A (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004055239A1 (en) * 2002-12-13 2004-07-01 Korea Power Engineering Company, Inc. Apparatus for cathodic protection in an environment in which thin film corrosive fluids are formed and method thereof
CN100396819C (zh) * 2002-12-13 2008-06-25 韩国电力技术株式会社 在形成薄膜腐蚀流体的环境中用于阴极保护的装置及方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371032A1 (en) * 1999-04-30 2000-11-09 Chiron Corporation Neisseria genomic sequences and methods of their use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004055239A1 (en) * 2002-12-13 2004-07-01 Korea Power Engineering Company, Inc. Apparatus for cathodic protection in an environment in which thin film corrosive fluids are formed and method thereof
CN100396819C (zh) * 2002-12-13 2008-06-25 韩国电力技术株式会社 在形成薄膜腐蚀流体的环境中用于阴极保护的装置及方法

Also Published As

Publication number Publication date
IL98839A0 (en) 1992-07-15
NO912823L (no) 1992-01-20
CA2050635A1 (en) 1992-01-20
JPH0616569A (ja) 1994-01-25
FI913475A0 (fi) 1991-07-18
PT98382A (pt) 1992-05-29
MX9100275A (es) 1992-02-28
FI913475A (fi) 1992-01-20
JPH0655679B2 (ja) 1994-07-27
NO912823D0 (no) 1991-07-18
AU8113691A (en) 1992-01-23
NZ238974A (en) 1992-12-23

Similar Documents

Publication Publication Date Title
Dyrberg et al. Peptides as antigens. Importance of orientation.
EP0232717B1 (en) Antibody specific to low-molecular weight substance and method of producing the same by using colloidal metal particles as carrier
Leclerc et al. A synthetic vaccine constructed by copolymerization of B and T cell determinants
CA2078694A1 (en) Hepatitis b vaccine
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
HOSODA et al. Effect of bridge heterologous combination on sensitivity in enzyme immunoassay for cortisol
KR940703851A (ko) E형 간염 바이러스 펩타이드 항원 및 항체(hepatitis e virus peptide antigens and antibodies)
ES2176347T3 (es) Modulacion de la respuesta inmune.
DE69019190D1 (de) Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung.
Sakai et al. Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix
JP2003525014A5 (ko)
WO1999013907A3 (en) Methods to improve immunogenicity of antigens and specificity of antibodies
Simons et al. Mechanism of lymphocyte transformation induced by phytohaemagglutinin
KR920002632A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질 및 이를 함유하는 백신
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
EP0582243A3 (de) HCV Peptidantigene und Verfahren zur Bestimmung von HCV.
Norins et al. Globulins on NZB mouse erythrocytes
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질
Park et al. Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope
JP2553159B2 (ja) 赤血球凝集アッセイ
CN107488232A (zh) 一种His标签抗原的合成方法
Roth et al. Chronology of halothane-induced antigen expression in halothane-exposed rabbits.
Beuvery et al. Meningococcal group C polysaccharide/tetanus toxoid conjugate as immunogen.
CN103163302B (zh) 一种采用定向交叉偶联技术制备的短肽抗体试剂盒
Aithal et al. An alternate method utilizing small quantities of ligand for affinity purification of monospecific antibodies

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid